Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
John L. Beyer, MD: Patterns of Pharmacotherapy and Treatment Response in Elderly Adults with Bipolar Disorder
1
x
$
30.00
The Use of Prazosin in Treatment of Drug Dreams in Adolescents with Substance Use Disorder: Two Case Reports (OPEN ACCESS)
1
x
$
0.00
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
Reseña educativa: Lineamientos del concenso de expertos para el tratamiento farmacológico del trastorno bipolar: una nueva herramienta terapéutica
1
x
$
0.00
Intrathecal Morphine Delivery at Cisterna Magna to Control Refractory Cancer-Related Pain: A Prospective Cohort Study
1
x
$
30.00
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis
1
x
$
30.00
Neuropharmacology of Paroxetine
1
x
$
30.00
Nunzio Pomara, MD: Therapeutic Implications of HPA Axis Abnormalities in Alzheimer’s Disease: Review and Update
1
x
$
30.00
VOL 3 No. 7 Full Issue - July 2001
1
x
$
20.00
The Metabolism of Prostate Malignancy: Insight Into the Pathogenesis of Prostate Cancer and New Approaches for Its Diagnosis and Treatment
1
x
$
0.00
Jamie D. Feusner - Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
1
x
$
30.00
View Cart
Checkout
Home
Store
“Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial” has been added to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Establishing a ‘Gateway’ for Patients with Anxiety
$
0.00
Add to cart
Details
WHEN BIGGER IS BETTER: Necessity as the Mother of Medical Invention
$
0.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
Gender and Schizophrenia
$
0.00
Add to cart
Details
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
$
0.00
Add to cart
Details
Psychiatric Bulletin: Late-Breaking Clinical News
$
0.00
Add to cart
Details
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate
$
0.00
Add to cart
Details
Cause & Effect: Dealing with the Loss of a Spouse
$
0.00
Add to cart
Details
Anxiety Disorders: Vast Progress but a Long Journey Ahead
$
0.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
Panic Disorder During Pregnancy
$
0.00
Add to cart
Details
Recognition and Treatment of Anxiety Disorders in Primary Care
$
0.00
Add to cart
Details
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
$
0.00
Add to cart
Details
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
$
0.00
Add to cart
Details
Nota del Director Editorial: En vivo desde Nueva York, les presentamos Psiquiatría y Salud Integral
$
0.00
Add to cart
Details
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
$
0.00
Add to cart
Details
Psiquiatría y Salud Integral: El consejo editorial de PSI incluye los siguientes psiquiatras y médicos:
$
0.00
Add to cart
Details
Utilización del nombre de los fármacos
$
0.00
Add to cart
Details
1
2
…
44
Next
Page load link
Go to Top
